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ABSTRACT The baculovirus Autographa californica nu-
clear polyhedrosis virus (AcMNPV, which is representative of
the MNPV subtype in which the virions may contain many
nucleocapsids within a single viral envelope) encodes a protein,
v-ubi, that has 76% identity with the eukaryotic protein
ubiquitin. Transcriptional mapping indicated that the gene for
v-ubi was transcribed during the late phase of viral infection.
Two transcriptional start sites potentially encoding v-ubi were
identified. Both sites were contained within a sequence motif
common to baculovirus late genes. A recombinant virus,
AcUbi-flGal, encoding a ubiquitin-,8-galactosidase fusion pro-
tein was constructed to monitor the temporal regulation of
v-ubi gene during viral infection. The fusion protein was
expressed maximally at 14-18 hr postinfection, consistent with
its classification as a late protein. The amount of ubiquitin-
fi-galactosidase fusion protein that accumulated in AcUbi-
fiGal-infected cells by 48 hr postinfection was "14% of the
level of 8-galactosidase that was synthesized under control of
the polyhedrin promoter. Transcriptional analysis confimed
that synthesis of the fusion protein was directed by the v-ubi
gene promoter. AcUbi-I3Gal also produced normal levels of
authentic viral ubiquitin message. Southern blot analysis of
AcUbi-IlGal and 15 additional isolates revealed that the fusion
sequences had not recombined at the ubiquitin locus. A poly-
ubiquitin gene was isolated and sequenced from Spodoptera
frugiperda, a lepidopteran host cell line for AcMNPV. The
predicted amino acid sequence of the product of the host gene
is identical to animal ubiquitin.
Ubiquitin is a small eukaryotic protein involved in a number
of basic cellular processes (1, 2). The amino acid sequence of
ubiquitin is highly conserved, differing by only three amino
acids between animals, yeast, and plants. Ubiquitin is abun-
dant in cells, both free and covalently joined to an array of
acceptor proteins. All of the known functions of ubiquitin are
mediated through conjugation of ubiquitin to an acceptor
protein via an isopeptide bond between the C-terminal gly-
cine residue of ubiquitin and the E-amino group of a lysine
residue in the acceptor protein. A major function of ubiquitin
is to mark proteins for selective elimination. Several ubiquitin
molecules are attached sequentially to these "targeted"
proteins to form branched ubiquitin-ubiquitin conjugates in
which the C-terminal Gly-76 of one ubiquitin is joined to the
internal Lys-48 of an adjacent ubiquitin (3). The attachment
of a multiubiquitin chain is apparently essential for the
degradation of a variety of proteins via the ubiquitin-
dependent protease.
Another role that has been suggested for ubiquitin is the
reversible attachment of ubiquitin to a protein, which mod-
ulates protein function without targeting the protein for
degradation. Stable ubiquitin acceptors include histones H2A
and H2B (4), actin (5), the growth hormone receptor (6), and
the lymphocyte homing receptor (7). The existence of these
stable ubiquitin-protein conjugates is apparently explained
by the observation that these proteins are monoubiquitinated
and therefore do not activate the ubiquitin-dependent prote-
ase.
Ubiquitin is encoded by multiple genes in all organisms
examined to date; these genes direct the synthesis of poly-
ubiquitin or ubiquitin fusion proteins. The polyubiquitin
genes contain tandem arrays of ubiquitin coding regions with
repeat lengths varying from 5 in yeast (8) to 18 in Drosophila
(9). Stop codons are not present between the coding units,
and cleavage at the Gly-Met bonds between each ubiquitin
molecule generates monomers from a polyubiquitin transla-
tion product. The single ubiquitin coding regions are fused to
carboxyl-terminal extensions of 52 or 76-80 amino acids.
Expression of the fusion proteins and polyproteins is differ-
entially regulated in yeast cells and probably in other orga-
nisms as well. In normally growing cells, most ubiquitin is
generated from the fusion proteins. The polyubiquitin gene is
dispensable in growing cells but is essential during stress as
the main source of ubiquitin (8).
It recently has been reported that the extension proteins
are ribosomal proteins (10, 11), and the association of the
extension proteins with ubiquitin facilitates ribosome assem-
bly. This observation suggests that an additional function of
ubiquitin may be to serve as a "molecular chaperone" for the
incorporation of specific proteins into cellular structures (10).
Ubiquitin molecules are covalently linked to tobacco mo-
saic virus coat protein subunits (12). Quantitative analysis
indicated that approximately one subunit per virion is ubiq-
uitinated. Recently, 18 viruses from several different virus
families were examined for the presence of ubiquitinated
proteins in purified virions (13). The majority of these viruses
were found to contain proteins that cross-reacted with affin-
ity-purified anti-ubiquitin antibody. The function of these
ubiquitinated proteins in the virus is unknown; but their
widespread occurrence indicates that ubiquitin may play a
role in viral life cycles. Alternatively, ubiquitination of viral
proteins could be a common host response to the stress of
virus infection.
This analysis included a member of the Baculoviridae.
Baculoviruses are complex DNA viruses that infect inverte-
brate organisms (14). These viruses have the potential to
encode -100 proteins. In this report, we show that one of the
proteins, v-ubi, encoded by the baculovirus Autographa
californica nuclear polyhedrosis virus (AcMNPV, which is
representative of the MNPV subtype in which virions may
contain many nucleocapsids within a single viral envelope)
shares 76% identical amino acids with animal ubiquitin, while
the amino acid sequence of ubiquitin from a lepidopteran host
Abbreviations: AcMNPV, Autographa californica nuclear polyhe-
drosis virus, which is representative of the MNPV subtype in which
the virions may contain many nucleocapsids within a single viral
envelope; v-ubi, viral ubiquitin-like protein.
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cell line is identical with the animal protein. Analysis of
infected cell proteins indicated that v-ubi is highly expressed
during the late phase of viral infection.
MATERIALS AND METHODS
DNA Sequencing. The nucleotide sequence of the Pst I K
fragment of AcMNPV* was determined by a combination of
subcloning restriction fragments and making nested deletions
with exonuclease III (15, 16). Host ubiquitin genes were
selected from a A phage EMBL3 library of Spodoptera
frugiperda DNA by using a Drosophila ubiquitin probe (9)
and standard cloning techniques (17). Xho I fragments of
ubiquitin monomers were subcloned into phage M13 and
sequenced. Sequences were compiled and analyzed by using
the programs of Devereaux et al. (18).
Construction of Viral Mutants. The transfer plasmid pUbi-
f3Gal was constructed by cloning a Sal I fragment ofpMC1871
(19) into the Aft II site of Pst I K fragment after repair of both
ends with the Klenow fragment of Escherichia coli DNA
polymerase I by standard cloning techniques (17). Viral
recombinants were selected after cotransfection of S. fru-
giperda cells with pUbi-,3Gal and viral DNA (20).
Analysis of Viral Infected Cells. S. frugiperda cells were
infected and labeled as described (21). Intracellular protein
extracts were prepared by treating the cells for 20 min on ice
with extraction buffer [50 mM Tris HCl, pH 8.0/100 mM
NaCI/1% Nonidet P-40/1% Empigen BB (Albright & Wilson,
Whitehaven, U.K.)], microcentrifuging the extract for 10
min, and harvesting the supernatant fluid. Extracts were
mixed with an equal volume of 2 x sodium dodecyl sulfate
(SDS) sample buffer (0.125 M Tris, pH 6.8/4% SDS/2%
2-mercaptoethanol/20% glycerol) and analyzed on 8% poly-
acrylamide gels. For immunoblot (Western) analysis, pro-
teins were electrophoretically transferred to nitrocellulose
sheets with a semidry apparatus according to the recommen-
dations of the manufacturer (American Bionetics, Hayward,
CA). After transfer, the nitrocellulose sheet was treated with
blocking buffer and probed with mouse monoclonal anti-
,B-galactosidase IgG. The blot was subsequently probed with
alkaline phosphatase-conjugated goat anti-mouse IgG and
developed with a standard alkaline phosphatase color reac-
tion. Total cell RNA was purified from cells infected with
wild-type virus at 6 and 18 hr postinfection or with the
AcUbi-,3Gal fusion virus at 18 hr postinfection. RNA was
hybridized with an Afl II-Nsi I fragment 5'-end-labeled at the
Aft II site or with an EcoRI-Nsi I fragment 5'-end-labeled at
the EcoRI site. The RNA isolation, end-labeling, and S1
nuclease analysis were conducted as described (22). Assays
for,8-galactosidase activity were performed by using a mod-
ification of the method of Zamn and Fowler (23). A unit of
,l-galactosidase is the amount of enzyme that produces 1
nmol of o-nitrophenol per min at 28°C at pH 7.0.
RESULTS
A map of the AcMNPV Pst I K fragment (21.0-23.5 map
units) is presented in Fig. 1A. This region of the viral genome
contains the gene for the 39-kDa protein ("39K gene") that
has been used extensively for mapping immediate early viral
regulatory genes (22). Sequence analysis ofDNA flanking Pst
I K fragment revealed the presence of a small open reading
frame located downstream and on the opposite strand of the
39K gene. A search of the National Biomedical Research
Foundation protein bank showed 76% identity with animal
ubiquitin. This viral gene encoding ubiquitin-like v-ubi en-
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ATCGATCACCTCGCCCAAGTGGCCCGGTGTTATATTAAGTCGTTTGAAAGCAT
CTATCGCTTCTTGCACGTCGGCCTGATAATTTTTGACCACGGGCGTGGAAATCAATTGC
CGTTGAAGGGAAATAATTCGTGGTGTGGGTATCGGCCGCCTGTTGCACAATTCCACCAG
CGGTGGAGGCAAGGGCGCATTCACAGCAACCGTTGTCATTTATAAGTAATAGTGTAAAA
V-ubi ATG CAA ATA TTC ATC AAA ACA TTG ACG GGC AAA ACC ATT ACC GCC
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Sf-Ubi val. e
Sf-Ubi ATG CAA ATT TTT GTC AAG ACC CTG ACT GGT AAG ACT ATC ACT CTC
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V-ubi GCC GAT AAA GAA GGT GTG CCC GTA GAT CAA CAA AGA CTT ATC TTT
V-ubi ala asp lys glu gly val pro val asp gin gin arg leu ilu phe
Sf-Ubi gin ilu pro
Sf-Ubi CAG GAC AAG GAG GGT ATC CCC CCA GAC CAA CAG CGA TTG ATC TTC
V-ubi GCG GGC AAA CAA CTG GAA GAT TCC AAA ACT ATG GCC GAT TAC AAT
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Sf-Ubi GCC GGC AAG CAG CTG GGA GAC GGC CGC ACT CTC TCC GAC TAC AAT
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ATT CAG AAG GAA TCT ACT CTT CAC ATG GTG TTA CGA TTA CGA GGA
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leu
ATT CAG AAG GAG TCC ACC CTT CAC TTG GTC TTT CGT CTG CGT GGT
GGG TAT TAATAATAACAATAATAAAAACCGATTAAATATACATAAAAGTTTTTTATT
gly tyr *
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FIG. 1. Nucleotide sequence of the AcMNPV ubiquitin gene and
the predicted amino acid sequence of v-ubi. (A) Map of the Pst I K
fragment of the AcMNPV genome. The location and direction of
transcription of the genes encoding the 39-kDa protein and v-ubi are
indicated. (B) Nucleotide sequence and predicted amino acid se-
quences of v-ubi and S. frugiperda ubiquitin (Sf-Ubi). The coding
region and flanking sequences are shown for v-ubi; the sequence of
a single Xho I monomer is shown for ubiquitin. Identical residues in
both sequences are indicated by a dot in the S. frugiperda sequence,
while differences are indicated by the correct amino acids. The Afl
11 restriction site in the viral DNA that was used for S1 nuclease
mapping and cloning of the /3-galactosidase gene is underlined. The
transcriptional start sites are indicated by asterisks, and the sequence
homologous to the conserved sequence found in baculovirus late
genes is indicated by a dotted underline.
codes 77 amino acids rather than the 76 residues found in
mature ubiquitin. The products of yeast, chicken, and Dro-
sophila polyubiquitin genes contain extra C-terminal residues
following glycine-76 (8, 9, 24).
The nucleotide sequence and deduced amino acid se-
quence of this region of Pst I K fragment is presented in Fig.
1B. The predicted amino acid sequence for v-ubi differs from
the animal ubiquitin sequence at 18 residues in addition to the
C-terminal tyrosine. Ten of the substitutions are conservative
with respect to the side group, and the numbers of acidic and
basic residues are the same as in animal ubiquitin. Two
features known to be important for ubiquitin function are
conserved in the viral protein. The lysine-48 residue, neces-
sary for branched-chain multiubiquitin adducts (3), is pres-
ent. The glycine-glycine dipeptide (positions 75-76) is also
conserved. This sequence is essential for cleavage of the
terminal residue and conjugation to acceptor proteins (25).
The presence of ubiquitin from lepidopteran insects has not
been reported previously. To determine whether the viral
ubiquitin sequence was virus-specific or whether it was
derived from its lepidopteran host, the nucleotide sequence
of the host ubiquitin gene was determined. Ubiquitin genes
were selected from a phage A EMBL3 library of S. frugiperda
DNA by using a Drosophila ubiquitin probe (9). Both
strongly and weakly hybridizing plaques were detected.
DNA was purified from the strongly hybridizing plaques and
subjected to partial restriction digestion with Xho I, which
cuts each ubiquitin monomer once (Fig. 2A). This number of
bands in the partial digest indicated that the 228-bp ubiquitin-
*The sequences reported in this paper have been deposited in the
GenBank data base (accession nos. M30305 for the viral ubiquitin
sequence and M30306 for the host ubiquitin sequence).
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FIG. 2. Southern blot analysis of DNA encoding S. frugiperda
polyubiquitin and v-ubi. (A) Tandem ubiquitin-encoding repeats in S.
frugiperda polyubiquitin gene. A phage A genomic clone containing
the S. frugiperda polyubiquitin gene was partially digested with Xho
I. The DNA was separated on a 0.8% agarose gel and blotted onto
nitrocellulose. The filters were hybridized with a Drosophila ubiq-
uitin probe (9). The positions of the 228-base-pair (bp) ubiquitin
monomer and the ubiquitin 12-mer are indicated. (B) Southern blot
analysis of wild-type AcMNPV and AcUbi-f3Gal. Viral DNA was
digested with Pst I and separated on a 0.8% agarose gel, stained with
ethidium bromide, and visualized with UV light (lanes 1-3). The gel
was blotted onto nitrocellulose, and the filter was hybridized with a
1.5-kilobase (kb) Xma III subfragment of Pst I K fragment encoding
V-ubi (lanes 4-6). The locations of the viral Pst I fragments and the
Ubi-pGal fusion sequences are indicated on the right. Lanes: 1 and
4, HindIll fragments of phage A DNA; and 5, wild-type AcMNPV
DNA; 3 and 6, AcUbi-flGal DNA.
coding region is repeated 12 times in tandem. Several ubi-
quitin monomers were subcloned and sequenced. The nucle-
otide sequence of the monomers varied, especially at the
third codon position; however, the predicted amino acid
sequences of the repeats were identical to each other and to
that of animal ubiquitin (Fig. 1B).
Eukaryotic organisms contain at least three different genes
that encode polyubiquitin and ubiquitin fusion proteins. To
determine whether the AcMNPV genome contained addi-
tional ubiquitin-like genes, a 1.5-kb Xma III fragment of the
plasmid Pst I K fragment containing the v-ubi coding region
was used to probe Pst I-digested viral DNA. The autoradio-
gram revealed a single radioactive band that migrated with
Pst I K fragment, indicating that the virus contains only one
gene with homology to ubiquitin (Fig. 2B).
To determine whether the viral ubiquitin gene was tran-
scribed in infected cells, S1 nuclease analysis was performed
with RNA purified from AcMNPV-infected cells at 6 and 18
hr postinfection. Two protected fragments were detected
with 18-hr RNA, none with 6-hr RNA (Fig. 3). To precisely
map the transcriptional start sites, the protected fragments
were analyzed in lanes adjacent to a Maxam-Gilbert (26)
sequencing ladder of the probe. The corresponding transcrip-
tional start sites are indicated in Fig. 1. The 5' proximal AUG
_1W FIG. 3. S1 nuclease protec-
tion analyses of v-ubi tran-
scripts. RNA was purified from
S. frugiperda cells infected with
wild-type virus at 0 (lane 5), 6
(lane 6), or 18 hr (lane 7) or from
cells with AcUbi-,3Gal (lane 8)
and hybridized with a the Afl
Il-Nsi I probe, specifically 5'-
end-labeled at the Afl 11 site. A
set of Maxam-Gilbert (26) se-
quencing ladders of the same
fragment is shown in lanes 1-4,
(corresponding to GATC). RNA
i was purified from cells infected
with AcUbi-/3Gal and purified at
0 (lane 9) or 18 hr (lane 10) and
hybridized with an EcoRI-Nsi I
fusion-specific probe. The cor-
V responding sequencing ladder is
presented in lanes 11-14 (corre-
sponding to GATC). The posi-
tions of the S1 nuclease-pro-
tected fragments is indicated on
the right.
for both transcripts is the initiation codon for v-ubi. The
major site of transcription initiation is located 197 nucleotides
upstream of the methionine codon. The minor site is 18
nucleotides upstream of the initiation codon. Both promoter
regions are contained within conserved motifs located near
the transcriptional start sites of highly expressed baculovirus
late genes (27).
To investigate whether the gene for v-ubi translated in
infected cells, a recombinant virus containing the f3-galact-
osidase gene under the control of the v-ubi gene was pro-
duced. A fragment encoding ,3-galactosidase was inserted in
frame with the coding region at the Afl II site indicated in Fig.
1. The resulting construct should encode f3-galactosidase
with 26 amino acids of v-ubi fused to the N terminus. This
plasmid (pUbi-p8Gal) contained 1.2 kb of ubiquitin flanking
sequence upstream and 2.0 kb downstream of the fusion
gene. S. frugiperda cells were cotransfected with pUbi-,BGal
and viral DNA. Progeny virus was plaque-purified in the
presence of the chromogenic substrate Bluo-gal (Bethesda
Research Laboratories). A Ubi-/3Gal recombinant was used
to monitor the time of expression of v-ubi during virus
infection. S. frugiperda cells were infected with wild-type
(AcMNPV) virus or one of the Ubi-f3Gal recombinants
(AcUbi-/3Gal). At the indicated times postinfection, cells
were pulse-labeled with [32S]methionine for 4 hr. As a con-
trol, nonfused -galactosidase was expressed from the poly-
hedrin promotor by infection of S. frugiperda cells with
VL720-,3Gal (28), and cells were radiolabeled from 44 to 48
hr postinfection. Protein extracts were analyzed on duplicate
SDS/polyacrylamide gels (Fig. 4). One gel was dried and
exposed to film (Fig. 4A). A radiolabeled protein that mi-
grated more slowly than nonfused f-galactosidase was de-
tected in cells infected with AcUbi-,3Gal but not in cells
infected with wild-type virus. Synthesis of the Ubi-,BGal
fusion protein was first detected at 8-12 hr postinfection, was
maximal at 14-18 hr postinfection, and declined at later
times. This pattern of synthesis is characteristic of late or
y-phase genes. The other gel was transferred to nitrocellulose
A
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FIG. 4. Temporal expression of AcMNPV ubiquitin. At the indicated times postinfection, cells were pulse-label with Tran35S-labeled (ICN;
a mixture of 35S-labeled cysteine/methionine) for 4 hr. At the end of the labeling period, intracellular protein extracts were prepared. Extracts
were analyzed on duplicate SDS/polyacrylamide gels. Nonfused 13-galactosidase was synthesized in cells infected with the AcMNPV
recombinant pVL720-,3Gal. Each lane represents 1 x 104 cells. One gel was dried and exposed to film as shown in A. Lanes: 1-7, time course
of cells infected with the AcUbi-/3Gal recombinant; 8 cell extracts 48 hr postinfection with pVL720-13Gal; 9-15 time course of cells infected with
wild-type AcMNPV. Labeling was postinfection from 0 to 4 hr (lanes 1 and 9), from 4 to 8 hr (lanes 2 and 10), from 8 to 12 hr (lanes 3 and 11),
from 14 to 18 hr (lanes 4 and 12), from 22 to 26 hr (lanes 5 and 13), from 32 to 36 hr (lanes 6 and 14), and from 44 to 48 hr (lanes 7 and 15). The
positions of radiolabeled molecular markers (Bethesda Research Laboratories) run in the left-most lane are indicated on the left. The other gel
was used for immunoblot analysis as shown in B. The bands corresponding to the ubiquin-f3-galactosidase fusion protein (U-fBgal) and nonfused
,B-galactosidase (,Bgal) are indicated on the right. Lanes 1-8 contain the same samples are presented in A. The positions of prestained molecular
markers analyzed in the left-most lane are indicated on the left.
and probed with anti-pB-galactosidase (Fig. 4B). Immunoblot
analysis indicated a major reactive species in the AcUbi-
,3Gal-infected cells migrating more slowly than nonfused
f3-galactosidase produced under the control of polyhedrin.
The fusion protein was detectable at a low level in the 12-hr
time point and remained at a maximum, constant level from
18 to 48 hr postinfection. Densitometric analysis of the
separate immunoblot containing serial dilutions of both ex-
tracts indicated that the amount of P-galactosidase produced
under control of the v-ubi gene promoter was 414% of that
synthesized in VL720-BGal-infected cells under the control
of the polyhedrin promoter at 48 hr postinfection. This result
was confirmed by enzymatic analysis of f3-galactosidase in
extracts of cells infected with both recombinants. Cells
infected with VL720-,BGal produced 0.29 units of /3-
galactosidase per 106 cells, while AcUbi-,/Gal-infected cells
produced 0.035 units per 106 cells.
To confirm that the message encoding the fusion protein
was expressed under the control of the ubiquitin promoter,
RNA was purified from cells infected with AcUbi-p3Gal at 18
hr postinfection and subjected to S1 nuclease analysis by
using a probe specific for the fusion sequences (Fig. 4). As
predicted by the cloning strategy, the fragments protected by
the Ubi-,SGal probe were 19 nucleotides longer than the
fragments protected by the v-ubi probe. Comparison of the
sequencing ladder indicated that the messages initiated at the
same site as authentic v-ubi mRNA. The recombinant cells
also expressed authentic v-ubi mRNA, as detected by S1
nuclease analysis. Expression of the /B-galactosidase-
ubiquitin fusion protein strongly suggests that v-ubi mRNA is
translated in infected cells.
Restriction- analysis of the genomic DNA AcUbi-,3Gal
indicated that fusion sequences had not recombined into the
ubiquitin locus of the virus (Fig. 2B). Instead, the DNA had
inserted into the region of the Pst I G fragment, which has
previously been shown to be hypermutable (29). Four addi-
tional recombinants were purified as blue-plaque viruses, and
three recombinants were identified by using radioactive
probes to detect the B-galactosidase gene sequence. Southern
blot analysis ofthese viruses also indicated that recombinants
had not deleted v-ubi gene (data not shown). To increase the
efficiency of allelic recombination, the Pst I K fragment
containing the Ubi-p3Gal sequences was cloned into pXho I H
fragment (19.1-24.1 map units). This plasmid, pXho I-H/
Ubi-pGal, contains 3.7 kb upstream and 3.8 kb downstream
of v-ubi gene. After cotransfection with viral DNA, eight
additional recombinant viruses were plaque-purified. South-
ern blot analysis of these recombinants again indicated that
recombination had not occurred in the v-ubi locus (data not
shown).
DISCUSSION
It has recently been shown that ubiquitin is covalently linked
to coat protein subunits of several different plant and animal
viruses (13). The function of these ubiquitinated proteins is
unknown. However, their apparently widespread occurrence
suggests that ubiquitin may play a role in virus life cycles or in
virus-host interactions. This manuscript showing that a ubiq-
uitin variant is encoded by the baculovirus AcMNPV strength-
ens this hypothesis. Although the primary sequence of v-ubi
differs from canonical ubiquitin, it is possible that v-ubi retains
some or all ofthe functions normally associated with ubiquitin.
Most of the amino acid substitutions are conservative with
respect to the side group, and many of the residues known to
be important for function have been conserved.
Two genes encoding ubiquitin-like proteins have been
described (Fig. 5). One example is GDX, a constitutively
expressed gene located on the human X chromosome (30).
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FIG. 5. Sequence comparison of ubiquitin-like proteins. The
amino acid sequence of animal ubiquitin (Ubi) is compared to that for
AcMNPV ubiquitin (V-ubi), the carboxyl domain of the interferon-
induced homologue of ubiquitin (UCRP), and the human X chromo-
some protein (GdX). The alignment was done by using the programs
of Devereaux et al. (18). Capitol letters indicate identical amino acids,
while lower-case letters indicate substitutions relative to the animal
sequence. The identical and conserved amino acids are boxed.
GDX encodes a protein of 157 amino acids. The amino-
terminal 76 amino acids of GDX are 43% identical with
ubiquitin; the homology is 57% if conservative substitutions
are considered. Another example of a ubiquitin-like protein
is the interferon-induced protein UCRP (31). This 15-kDa
protein consists of two domains, both of which have homol-
ogy with ubiquitin. Only the carboxyl-terminal domain is
presented in Fig. 4. This region of UCRP is 28% identical or
57% homologous with ubiquitin. The functions of these
ubiquitin-like proteins and v-ubi are unknown. However, it
may be of interest to note that identical substitutions are
found in four residues in GDX, UCRP, and v-ubi. Three of
these substitutions are conservative substitutions: valine for
Ile-23 and leucine for Val-26 and Ile-36. The fourth, glutamine
for Ala-28, is not conservative with respect to side group.
Structure-function analysis of canonical ubiquitin and the
variants may yield clues as to their functions. Because of
amino acid substitutions in the Gly-Gly dipeptide, it is
unlikely that the GDX and UCRP proteins are processed to
yield monomers of ubiquitin. However, v-ubi is expected to
be a substrate for the enzymes that normally process ubiq-
uitin fusion proteins to yield a monomer of ubiquitin (32).
In an attempt to determine whether v-ubi was essential in
the virus life cycle, the bacterial gene for -galactosidase was
cloned into the v-ubi locus in the plasmid pPst I K fragment.
Sixteen recombinant viruses were selected according to
standard procedures. However, restriction enzyme and
Southern blot analyses revealed that correct allelic replace-
ment had not occurred; instead the transfer vector had
integrated into a region of the viral genome previously shown
to be hypermutable (29). This technique of producing mutants
by using 0-galactosidase has been useful for several genes of
AcMNPV (20, 33). If mutants can be selected, it indicates
that the gene in question is not essential for virus growth in
tissue culture. Although not definitive, inability to select for
ubi- mutants by this method suggests that the gene for v-ubi
is an essential gene.
The function of v-ubi is currently unknown. Proteins
expressed during the late phase of baculovirus infection are
primarily viral structural proteins. It is possible that the role
of this protein is to serve as a molecular chaperone for the
incorporation of viral proteins into particles. This would be
analogous to the proposed role of ubiquitin in the assembly
of ribosomes (10). Another possibility is that v-ubi plays a
role in the inhibition of host transcription and translation that
occurs during the late phase of infection. The mechanism for
this inhibition is unknown, but it is conceivable that the virus
could mediate these effects through inhibition of the host
ubiquitin system or ubiquitination of host regulatory genes.
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